Related references
Note: Only part of the references are listed.Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System
Mohamed Naguib et al.
ANESTHESIA AND ANALGESIA (2012)
Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells
Elisa Burgos et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Cannabinoid Type-1 Receptor Reduces Pain and Neurotoxicity Produced by Chemotherapy
Iryna A. Khasabova et al.
JOURNAL OF NEUROSCIENCE (2012)
Evidence That Spinal Astrocytes but Not Microglia Contribute to the Pathogenesis of Paclitaxel-Induced Painful Neuropathy
Haijun Zhang et al.
JOURNAL OF PAIN (2012)
Intrathecal cannabilactone CB2R agonist, AM1710, controls pathological pain and restores basal cytokine levels
Jenny L. Wilkerson et al.
PAIN (2012)
Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy
Amteshwar Singh Jaggi et al.
TOXICOLOGY (2012)
CXCR4 signaling mediates morphine-induced tactile hyperalgesia
Natalie M. Wilson et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Chemotherapy-Induced Peripheral Neuropathy: Prevention and Treatment
D. R. Pachman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Chemotherapy-Induced Neuropathy
Guido Cavaletti et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2011)
Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy
Huaien Zheng et al.
EXPERIMENTAL NEUROLOGY (2011)
Cannabis and Its Derivatives: Review of Medical Use
Lawrence Leung
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2011)
MITOCHONDRIAL ABNORMALITY IN SENSORY, BUT NOT MOTOR, AXONS IN PACLITAXEL-EVOKED PAINFUL PERIPHERAL NEUROPATHY IN THE RAT
W. H. Xiao et al.
NEUROSCIENCE (2011)
Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion
Mohd W. Nasser et al.
PLOS ONE (2011)
Pharmacological characterization of AM1710, a putative cannabinoid CB2 agonist from the cannabilactone class: Antinociception without central nervous system side-effects
Elizabeth J. Rahn et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Pharmacological Characterization of a Novel Cannabinoid Ligand, MDA19, for Treatment of Neuropathic Pain
Jijun J. Xu et al.
ANESTHESIA AND ANALGESIA (2010)
Spatio-temporal changes of SDF1 and its CXCR4 receptor in the dorsal root ganglia following unilateral sciatic nerve injury as a model of neuropathic pain
Petr Dubovy et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2010)
Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice
Lauren E. Ta et al.
MOLECULAR PAIN (2010)
Glutamate Carboxypeptidase Inhibition Reduces the Severity of Chemotherapy-Induced Peripheral Neurotoxicity in Rat
Valentina A. Carozzi et al.
NEUROTOXICITY RESEARCH (2010)
Chemokines, neuronal-glial interactions, and central processing of neuropathic pain
Yong-Jing Gao et al.
PHARMACOLOGY & THERAPEUTICS (2010)
Antinociceptive effect of three common analgesic drugs on peripheral neuropathy induced by paclitaxel in rats
David Pascual et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2010)
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain
Praveen Anand et al.
BRAIN RESEARCH REVIEWS (2009)
Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brain
Khalid Benamar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Roger G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Cellular and Molecular Mechanisms of Pain
Allan I. Basbaum et al.
CELL (2009)
The Endocannabinoid System and Pain
Josee Guindon et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy
Sonia K. Bhangoo et al.
MOLECULAR PAIN (2009)
Animal Models of Chemotherapy-Evoked Painful Peripheral Neuropathies
Nicolas Authier et al.
NEUROTHERAPEUTICS (2009)
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
J. Guindon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models
M. Naguib et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies
Sherry Wolf et al.
EUROPEAN JOURNAL OF CANCER (2008)
CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain
Ling Cao et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy
Giorgia Melli et al.
EXPERIMENTAL NEUROLOGY (2008)
Interaction of transient receptor potential vanilloid 4, integrin, and Src tyrosine kinase in mechanical hyperalgesia
Nicole Alessandri-Haber et al.
JOURNAL OF NEUROSCIENCE (2008)
First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain
Khalid Benamar et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
Elizabeth J. Rahn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Chemotherapy-induced neuropathy
Anthony J. Windebank et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2008)
Chemotherapy-evoked neuropathic pain: Abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitine
Wen Hua Xiao et al.
PAIN (2008)
Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons
Uma Anand et al.
PAIN (2008)
Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats
E. J. Rahn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Cannabilactones: A novel class of CB2 selective agonists with peripheral analgesic activity
Atmaram D. Khanolkar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain
Maulik D. Jhaveri et al.
MOLECULAR NEUROBIOLOGY (2007)
Pre-emptive antinociceptive effects of a synthetic cannabinoid in a model of neuropathic pain
Jose Guindon et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy
Sonia K. Bhangoo et al.
BRAIN BEHAVIOR AND IMMUNITY (2007)
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
Christel Rousseaux et al.
NATURE MEDICINE (2007)
Paclitaxel- and vincristine-evoked painful peripheral neuropathies: Loss of epidermal innervation and activation of Langerhans cells
Chiang Siau et al.
EXPERIMENTAL NEUROLOGY (2006)
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes
Sharmistha Ghosh et al.
MOLECULAR IMMUNOLOGY (2006)
Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: Evidence for mitochondrial dysfunction
SJL Flatters et al.
PAIN (2006)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats
DR Sagar et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation
AG Nackley et al.
JOURNAL OF NEUROPHYSIOLOGY (2004)
Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain
SJR Elmes et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
The role of N-methyl-D-aspartate (NMDA) receptors in pain:: A review
AB Petrenko et al.
ANESTHESIA AND ANALGESIA (2003)
Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain:: Pain inhibition by receptors not present in the CNS
MM Ibrahim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections
N Authier et al.
EXPERIMENTAL NEUROLOGY (2003)
A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel
RC Polomano et al.
PAIN (2001)
Chemotherapy-evoked painful peripheral neuropathy
RC Polomano et al.
PAIN MEDICINE (2001)
CXC chemokine receptor 4 expression and function in human astroglioma cells
JW Oh et al.
JOURNAL OF IMMUNOLOGY (2001)
Role of protein kinase C epsilon and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat
OA Dina et al.
NEUROSCIENCE (2001)
Share Paper
